Your browser doesn't support javascript.
loading
Aggressive immunotherapy combined with bortezomib and rituximab for membranous nephropathy associated with enzyme replacement therapy in Pompe disease.
Sasaki, Keigo; Uchimura, Toru; Inaba, Aya; Otani, Masako; Hanakawa, Junko; Ito, Shuichi.
Afiliação
  • Sasaki K; Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan.
  • Uchimura T; Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan.
  • Inaba A; Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan.
  • Otani M; Division of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
  • Hanakawa J; Department of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Ito S; Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan. itoshu@yokohama-cu.ac.jp.
Pediatr Nephrol ; 38(3): 921-925, 2023 03.
Article em En | MEDLINE | ID: mdl-35864224
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glomerulonefrite Membranosa / Doença de Depósito de Glicogênio Tipo II Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child, preschool / Humans / Male Idioma: En Revista: Pediatr Nephrol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glomerulonefrite Membranosa / Doença de Depósito de Glicogênio Tipo II Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child, preschool / Humans / Male Idioma: En Revista: Pediatr Nephrol Ano de publicação: 2023 Tipo de documento: Article